{"organizations": [], "uuid": "124d1402e99a940ad57254b60def804477632da5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-athenahealth-q4-adj-shr-111/brief-athenahealth-q4-adj-shr-1-11-idUSL8N1PR8P6", "country": "US", "domain_rank": 408, "title": "BRIEF-Athenahealth Q4 Adj Shr $1.11", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-02T01:10:00.000+02:00", "replies_count": 0, "uuid": "124d1402e99a940ad57254b60def804477632da5"}, "author": "", "url": "https://www.reuters.com/article/brief-athenahealth-q4-adj-shr-111/brief-athenahealth-q4-adj-shr-1-11-idUSL8N1PR8P6", "ord_in_thread": 0, "title": "BRIEF-Athenahealth Q4 Adj Shr $1.11", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "athenahealth", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "athenahealth inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 1 (Reuters) - Athenahealth Inc:\n* ATHENAHEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS\n* Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.11 * Q4 GAAP EARNINGS PER SHARE $0.78 * Q4 REVENUE ROSE 14 PERCENT TO $329.2 MILLION Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-02T01:10:00.000+02:00", "crawled": "2018-02-02T01:28:41.008+02:00", "highlightTitle": ""}